Recombinant proteins expressed as bacterial inclusion bodies (IBs) are now receiving
tremendous attention for many diverse applications in the areas of industrial and medical …

Inclusion bodies (IBs) often emerge upon overexpression of recombinant proteins in E. coli.
From IBs, refolding is necessary to generate the native protein that can be further purified to …

Recombinant protein production in bacteria is often accompanied by the formation of
aggregates, known as inclusion bodies (IBs). Although several strategies have been …

Expression of heterologous proteins in E. coli often leads to the formation of protein
aggregates known as inclusion bodies (IBs). Inclusion body aggregates pose a major hurdle …

The formation of inclusion bodies (IBs) during expression of recombinant therapeutic
proteins using E. coli is a significant hurdle in producing high-quality, safe, and efficacious …

Understanding the structure–function of inclusion bodies (IBs) in the last two decades has
led to the development of several mild solubilization buffers for the improved recovery of …

Throughout the twenty-first century, the view on inclusion bodies (IBs) has shifted from
undesired by-products towards a targeted production strategy for recombinant proteins …

Senecavirus A (SVA) is an emerging pathogen that negatively affects the pig industry in
China. Affected animals present vesicular lesions which are indistinguishable from other …

A detailed workflow to analyze the physicochemical characteristics of mammalian matrix
metalloproteinase (MMP-9) protein species obtained from protein aggregates (inclusion …

Due to the high mortality rate and an increase in breast cancer incidence, it has been
challenging for researchers to come across an effective chemotherapeutic strategy with …